Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis.

Link to article at PubMed

Related Articles

Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis.

Gastrointest Endosc. 2019 Oct 16;:

Authors: Iqbal U, Khara H, Hu Y, Khan MA, Ovalle A, Siddique O, Sun H, Shellenberger MJ

BACKGROUND AND AIMS: Acute cholangitis (AC) is characterized by abdominal pain, fever, and jaundice. The majority of the patients respond to medical management with intravenous hydration and antibiotics. Almost 20% to 30% require biliary drainage, and ERCP is the procedure of choice. We conducted a systematic review and meta-analysis to evaluate the impact of emergent biliary drainage on patients' outcomes.
METHODS: A comprehensive literature review was conducted by searching the Embase and PubMed databases from inception to April 2019 to identify all studies that evaluated the impact of timing of ERCP on patient outcomes. Our primary outcome was in-hospital mortality (IHM), and secondary outcomes were length of stay (LOS), organ failure, and 30 days' mortality. Fixed and random effects models were used to generate pooled measures of inpatient mortality, 30 days' mortality, and length of stay.
RESULTS: Nine observational studies including 7534 patients were included in the primary meta-analysis. IHM was significantly lower in patients who underwent emergent biliary drainage within 48 hours (OR, 0.52; 95% CI, 0.28 - 0.98). As a sensitivity analysis, we pooled the data from 2 population registry studies of 81,893 patients, which yielded consistent results for the main outcomes. LOS was also significantly lower in patients who underwent ERCP within 48 hours with mean difference of 5.56 days (95% CI, 1.59 - 9.53). Patients who underwent emergent ERCP also had lowers odds of 30 days' mortality (OR, 0.39; 95% CI, 0.14 - 1.08) and organ failure (OR, 0.69; 95% CI, 0.33 - 1.46).
CONCLUSIONS: Our study reveals that performing emergent ERCP within 48 hours in patients with AC is associated with lower IHM, 30 days' mortality, organ failure, and shorter LOS.

PMID: 31628955 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.